Cargando…
Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its poten...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010308/ https://www.ncbi.nlm.nih.gov/pubmed/33815113 http://dx.doi.org/10.3389/fphar.2021.632767 |
_version_ | 1783673036022480896 |
---|---|
author | Lin, Yiping Li, Yuke Zeng, Yuanlian Tian, Bin Qu, Xiaolan Yuan, Qianghua Song, Ying |
author_facet | Lin, Yiping Li, Yuke Zeng, Yuanlian Tian, Bin Qu, Xiaolan Yuan, Qianghua Song, Ying |
author_sort | Lin, Yiping |
collection | PubMed |
description | Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its potential as an anti-inflammatory and antitumor drug. To summarize the new biological and pharmacological data on MG, we screened the literature from January 2011 to October 2020. In this review, we provide an actualization of already known anti-inflammatory, cardiovascular protection, antiangiogenesis, antidiabetes, hypoglycemic, antioxidation, neuroprotection, gastrointestinal protection, and antibacterial activities of MG. Besides, results from studies on antitumor activity are presented. We also summarized the molecular mechanisms, toxicity, bioavailability, and formulations of MG. Therefore, we provide a valid cognition of MG. |
format | Online Article Text |
id | pubmed-8010308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80103082021-04-01 Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update Lin, Yiping Li, Yuke Zeng, Yuanlian Tian, Bin Qu, Xiaolan Yuan, Qianghua Song, Ying Front Pharmacol Pharmacology Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its potential as an anti-inflammatory and antitumor drug. To summarize the new biological and pharmacological data on MG, we screened the literature from January 2011 to October 2020. In this review, we provide an actualization of already known anti-inflammatory, cardiovascular protection, antiangiogenesis, antidiabetes, hypoglycemic, antioxidation, neuroprotection, gastrointestinal protection, and antibacterial activities of MG. Besides, results from studies on antitumor activity are presented. We also summarized the molecular mechanisms, toxicity, bioavailability, and formulations of MG. Therefore, we provide a valid cognition of MG. Frontiers Media S.A. 2021-03-17 /pmc/articles/PMC8010308/ /pubmed/33815113 http://dx.doi.org/10.3389/fphar.2021.632767 Text en Copyright © 2021 Lin, Li, Zeng, Tian, Qu, Yuan and Song. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Lin, Yiping Li, Yuke Zeng, Yuanlian Tian, Bin Qu, Xiaolan Yuan, Qianghua Song, Ying Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
title | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
title_full | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
title_fullStr | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
title_full_unstemmed | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
title_short | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
title_sort | pharmacology, toxicity, bioavailability, and formulation of magnolol: an update |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010308/ https://www.ncbi.nlm.nih.gov/pubmed/33815113 http://dx.doi.org/10.3389/fphar.2021.632767 |
work_keys_str_mv | AT linyiping pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate AT liyuke pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate AT zengyuanlian pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate AT tianbin pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate AT quxiaolan pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate AT yuanqianghua pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate AT songying pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate |